An angiotensin-derived peptide studied in synaptogenesis research.
Dihexa is a synthetic peptide derived from angiotensin IV, studied in synaptogenesis and neural-connectivity research models. It is an investigational research compound sold strictly as a research material.
In animal and in-vitro models, researchers have examined this compound's relationship to:
These are areas of laboratory investigation, not established outcomes in people. For primary literature, see PubMed — Dihexa research.
Part of the Neurological category. Related: Semax · Selank · Neurological hub
This compound is sold in the U.S. for research use only and is not approved for human consumption. The peptide compounding landscape shifted in 2026 — read our breakdown: The 2026 FDA Peptide Reclassification, Explained.
We only list vendors we have personally vetted and partnered with. None of our current verified partners stock Dihexa yet — we’re adding new vetted suppliers regularly. In the meantime, browse compounds our trusted vendors do carry.
Products discussed are for laboratory and research purposes only — not for human consumption.
No. Dihexa is an investigational research compound; it is not approved for human consumption and is sold for research use only.
Look for batch-specific, third-party Certificates of Analysis (COAs), transparent purity testing, U.S. sourcing, and a real reputation across independent review platforms. Our vendor reviews check all of these.
No. We're an independent research and comparison resource. We link to vetted third-party vendors and disclose every affiliate relationship.
Last reviewed June 2026. By the Peptides Uncaged Research Team.
Join the list for honest peptide breakdowns and ranking updates. No spam, ever.